Kolker_2017_J.Anaesthesiol.Clin.Pharmacol_33_402

Reference

Title : Neostigmine induced coronary artery spasm: A case report and literature review - Kolker_2017_J.Anaesthesiol.Clin.Pharmacol_33_402
Author(s) : Kolker S , Tzivoni D , Rosenmann D , Meyler S , Ioscovich A
Ref : J Anaesthesiol Clin Pharmacol , 33 :402 , 2017
Abstract :

Neostigmine is a cholinesterase inhibitor which does not cross the blood brain barrier and a commonly used for reversal of nondepolarizing muscle relaxants. In the following case report, we present a patient who developed coronary artery spasm, after the administration of repeated doses of neostigmine. Ours is the first case to demonstrate such a longstanding coronary artery vasospasm that lasted several hours in response to neostigmine, resulting in myocardial damage and left ventricular dysfunction. We would like to draw the attention of the anesthesiologists to this rare effect that may lead to perioperative cardiac complications.

PubMedSearch : Kolker_2017_J.Anaesthesiol.Clin.Pharmacol_33_402
PubMedID: 29109645

Related information

Citations formats

Kolker S, Tzivoni D, Rosenmann D, Meyler S, Ioscovich A (2017)
Neostigmine induced coronary artery spasm: A case report and literature review
J Anaesthesiol Clin Pharmacol 33 :402

Kolker S, Tzivoni D, Rosenmann D, Meyler S, Ioscovich A (2017)
J Anaesthesiol Clin Pharmacol 33 :402